Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adenosine A1 receptor (A1AR) is a G protein-coupled receptor that binds adenosine. It is widely distributed throughout the body, particularly in the brain, heart, and kidneys, and plays a crucial role in regulating various physiological functions, including sleep, neuronal activity, cardiac function, and renal blood flow. Activation of A1AR primarily inhibits adenylyl cyclase, leading to decreased cAMP levels, and modulates ion channels, resulting in inhibitory effects. As such, it is a drug target for cardiac arrhythmias, neuroprotection, and pain management.
Activation of Gi/o proteins leading to decreased cAMP levels, activation of potassium channels, and inhibition of calcium channels.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosine Receptor A1 (A1AR).